Form 8-K Genvor Inc For: Jun 24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 24, 2022

13155 Noel Road, Suite 900

Dallas, TX  75240

(Address of principal executive offices)

(214) 427-1921

(Registrant’s telephone number, including area code)

Allure Worldwide, Inc.

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.

On June 24, 2022, Genvor Incorporated, formerly known as Allure Worldwide, Inc., a Nevada corporation (the “Company”) filed with the State of Nevada a Certificate of Amendment to the Company’s Articles of Incorporation (the “Certificate of Amendment”), to (i) change the name of the Company to Genvor Incorporated, and (ii) amend and restate the Articles of Incorporation in their entirety.

The foregoing description of the Certificate of Amendment and its contents is qualified in its entirety by the full text of the Certificate of Amendment, which is filed as Exhibit 3.1 to, and incorporated by reference in, this report.

ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

On or about June 24, 2022, holders of approximately 52.67% of the outstanding shares of common stock of the Company acted by written consent in lieu of a meeting to approve the Certificate of Amendment described in Item 5.03 herein. The description of the Certificate of Amendment set forth in Item 5.03 herein is incorporated by reference into this Item 5.07.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

The exhibits listed in the following Exhibit Index are filed as part of this report:

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

You May Also Be Interested In

• Credicorp Ltd.: Credicorp Raises Annual Dividend 40% to S/35.0 per Share
• Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference Call
• New Exhibition 'Global Travelers' by Carole A. Feuerman: Master of Superrealism